Skip to content
Clinical Research Society

Clinical Research Society

International Society for Clinical Research and Translational Medicine

  • About Us
    • Executive Council
    • Committees
    • President’s Message
    • Code of Ethics
    • Our Logo
  • Membership
    • Professional Membership
    • Associate Membership
    • Student Membership
    • Institutional Membership
    • Membership Renewal
  • Training & Certification
    • GCP Certification
    • CRA Certification
    • CRC Certification
    • Emerging Clinical Research Professional
    • Project Management Certification
    • Training Demo
    • Register for Certification Exam
  • Careers
  • Contact

gilead

Clinical Research and Pharma News 

Gilead’s 4-drug combination pill Quad for HIV achieves endpoint

0 Comments atripla, gilead, HIV, quad

Earlier on Monday, Gilead Sciences Inc. announced that a late-stage study for a 4-drug combination pill “Quad,” intended to treat

Read more
Clinical Research and Pharma News 

Gilead resolves warning letter form US regulatory agency

0 Comments ambisome, gilead

NEW YORK (AP) —Gilead Sciences Inc. announced that the manufacturing issues highlighted in the FDA warning letter in September have

Read more
Clinical Research and Pharma News 

Gilead and J&J’s combination pill Complera receives FDA approval for HIV treatment

0 Comments complera, gilead, HIV, j&j

In an announcement earlier on Wednesday, Gilead said that Complera, the once-per-day combination treatment for HIV, has been approved by

Read more

Example Widget

This is an example widget to show how the Right Sidebar looks by default. You can add custom widgets from the widgets screen in the admin. If custom widgets are added then this will be replaced by those widgets.

Copyright © 2023 Clinical Research Society. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.

Offer the visitors your services or goods.

Describe what they will receive and how they will benefit from it.

Do not forget a coaxing call to action, but also a way to decline.
Put the final call to action.

  • Yes I want it!
  • No thank you!